SRTSF yields 2.26% · JNJ yields 2.14%● Live data
📍 SRTSF pulled ahead of the other in Year 1
Combined, SRTSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SRTSF + JNJ for your $10,000?
Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and parapharmaceutical products. It operates through four segments: Mass Market Cosmetics, Household Products, Other Sales, and Private Label Products. The company provides personal care products, including baby care, baby wash, grooming, hair care, hair colorant, hair styling, hand wash, oral care, personal hygiene, shaving, skin care, and sun care products, as well as deodorants and fragrances; and home care products, such as dishwashing, drainer care, food packaging, insect control, and shoe care products, as well as bathroom cleaners, cleaning tools, septic tank activators, and garbage bags. It also offers health care products comprising food supplements, health and self-care products, and skin and sun care products; cosmetics, including candle, make up, treatment, and home and other fragrance products; and professional products, such as cleaning tools, detergents, and food and other packaging products. The company offers its products through hypermarkets, supermarkets, groceries, beauty shops, and pharmacies. It operates in Greece, Poland, Romania, Bulgaria, Serbia, the Czech Republic, Slovakia, Hungary, North Macedonia, Bosnia, Portugal, Ukraine, Russia, Cyprus, and France, as well as exports its products to approximately 50 countries in Europe, Asia, Africa, and Oceania. The company was founded in 1930 and is headquartered in Athens, Greece.
Full SRTSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.